Switch to:
GuruFocus has detected 1 Warning Sign with Cascadian Therapeutics Inc $CASC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Cascadian Therapeutics Inc (NAS:CASC)
Other Current Liabilities
$0.26 Mil (As of Mar. 2017)

Cascadian Therapeutics Inc's other current liabilities for the quarter that ended in Mar. 2017 was $0.26 Mil.

Cascadian Therapeutics Inc's quarterly other current liabilities declined from Sep. 2016 ($0.80 Mil) to Dec. 2016 ($0.35 Mil) and declined from Dec. 2016 ($0.35 Mil) to Mar. 2017 ($0.26 Mil).

Cascadian Therapeutics Inc's annual other current liabilities declined from Dec. 2014 ($0.28 Mil) to Dec. 2015 ($0.15 Mil) but then increased from Dec. 2015 ($0.15 Mil) to Dec. 2016 ($0.35 Mil).


The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Related Terms

Total Current Liabilities

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Cascadian Therapeutics Inc Annual Data

Other Current Liab.

Cascadian Therapeutics Inc Quarterly Data

Other Current Liab.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)